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Mycoplasma bovis is known worldwide as a major bovine
pathogen. Increasing prevalence has been recently reported in
Northern Europe. Control ofM. bovis infections in cattle herds
is difficult as increasing antimicrobial resistance is reported,
and commercial vaccines are not available or not effective.
Therefore, preventive measures such as high biosecurity
standards guided by results of a highly specific and sensitive
diagnosis are essential.
A consortium of six European national veterinary institutes 
was established to evaluate the performance of PCR and 
ELISA diagnostic methods currently used by these institutes. 
For serodiagnosis two commercial ELISA test kits were used:
the Bio K302 ELISA (Bio-X Diagnostics, Rochefort, Belgium)
and the ID Screen ® Mycoplasma bovis ELISA (IDvet,
Grabels, France). These two tests were compared to an in-
house Western blot method as to be able to use a latent class
analysis statistical approach. A sample panel (n=180) was
compiled of sera from cattle from five countries with high and
low M. bovis prevalence. Sera were distributed to the six
laboratories and tested as recommended by the suppliers of
the test kits. Using latent class analysis, we found that the
diagnostic sensitivities of the Western blot, the ID Screen®
Mycoplasma bovis and the Bio K302 ELISA were 96.6 %, 99.6
% and 51.0 % respectively, and the diagnostic specificities were
99.8 %, 99.0 % and 85.7 % respectively (Table 1) (Andersson et
al., manuscript in preparation).
For evaluation of PCR diagnostics, a sample panel was tested
using five different DNA extraction methods, seven different
real-time and/or end-point PCR methods targeting four
different genes and six different real-time PCR platforms. Only
one commercial kit was assessed (MPBO50 kit from
ThermoFisher Scientific), all other were in-house PCR tests.
Three different assays were conducted to assess the specificity,
sensitivity and comparability of the PCRs. The sensitivity and
comparability assays were conducted using (n=21)
bronchoalveolar fluids of veal calves, artificially contaminated
or naturally infected. With a few exceptions, all methods run
routinely in the participating laboratories showed comparable
performance (Figure 1) (Wisselink et al., manuscript
submitted for publication).
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Table 1. Posterior median and 95% posterior credibility interval (95% PCI) of sensitivity and specificity 
for Western blot and the two ELISA systems obtained from latent class analysis, assuming conditional 
independence between tests and using informative or uniform priors.
Figure 1. Comparability of results of various PCR methods in use by six laboratories (Lab 1 to Lab 6) 
on bronchoalveolar lavage fluid (BALF) samples (n=21) from veal calves from farms with bovine 
respiratory disease (BRD). BALF samples were tested twice by the PCR methods and the mean Ct 
values were calculated from the real-time PCRs. Viability of M. bovis in the BALF samples was 
verified with culture. On the basis of the culture results, the figure was split in two parts, either with 
BALF samples negative or positive for M. bovis by culture.
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